Whole Transcriptomic Analysis of Apigenin on TNFα Immuno-activated MDA-MB-231 Breast Cancer Cells

Abstract

Background: Triple-negative breast cancer is categorized by a lack of hormone receptors, inefficacy of antiestrogen or aromatase inhibitor chemotherapies and greater mortality rates in African American populations. Advancedstage breast tumors have a high concentration of tumor necrosis factor-α (TNFα) throughout the tumor/stroma milieu, prompting sustained release of diverse chemokines (i.e. CC motif chemokine ligand 2 (CCL2)/CCL5). These potent chemokines can subsequently direct mass infiltration of leukocyte sub-populations to lodge within the tumor, triggering a loss of tumor immune surveillance and subsequent rapid tumor growth. Previously, we demonstrated that in the MDA-MB-231 TNBC cell line, TNFα evoked a rise in immune signaling proteins: CCL2, granulocyte macrophage colonystimulating factor, interleukin (IL)1α, IL6 and inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKε) all of which were attenuated by apigenin, a dietary flavonoid found in chamomile and parsley. Materials and Methods: The present work elucidates changes evoked by TNFα in the presence or absence of apigenin by examining the entire transcriptome for mRNA and long intergenic non-coding RNA with Affymetrix Hugene-2.1_ST human microarrays. Differential geneexpression analysis was conducted on 48,226 genes. Results: TNFα caused up-regulation of 75 genes and down-regulation of 10. Of these, apigenin effectively down-regulated 35 of the 75 genes which were up-regulated by TNFα. These findings confirm our previous work, specifically for the TNFα-evoked spike in IL1A vs. untreated controls [+21-fold change (FC), p<0.0001] being attenuated by apigenin in the presence of TNFa (−15 FC vs. TNFα, p<0.0001). Similar trends were seen for apigenin-mediated down-regulation of TNFα-up-regulated transcripts: IKBKE (TNFα: 4.55 FC vs. control, p<0.001; and TNFα plus apigenin: −4.92 FC, p<0.001), CCL2 (2.19 FC, p<0.002; and −2.12 FC, p<0.003), IL6 (3.25 FC, p<0.020; and −2.85 FC, p<0.043) and CSF2 (TNFα +6.04 FC, p<0.001; and −2.36 FC, p<0.007). In addition, these data further establish more than a 65% reduction by apigenin for the following transcripts which were also up-regulated by TNFα: cathepsin S (CTSS), complement C3 (C3), laminin subunit gamma 2 (LAMC2), (TLR2), toll-like receptor 2 G protein-coupled receptor class C group 5 member B (GPRC5B), contactin-associated protein 1 (CNTNAP1), claudin 1 (CLDN1), nuclear factor of activated T-cells 2 (NFATC2), C-X-C motif chemokine ligand 10 (CXCL10), CXCL11, interleukin 1 receptor-associated kinase 3 (IRAK3), nuclear receptor subfamily 3 group C member 2 (NR3C2), interleukin 32 (IL32), IL24, slit guidance ligand 2 (SLIT2), transmembrane protein 132A (TMEM132A), TMEM171, signal transducing adaptor family member 2 (STAP2), mixed lineage kinase domain-like pseudokinase (MLKL), kinase insert domain receptor (KDR), BMP-binding endothelial regulator (BMPER), and kelch-like family member 36 (KLHL36). Conclusion: There is a possible therapeutic role for apigenin in down-regulating diverse genes associated...

miR-1298-5p Influences the Malignancy Phenotypes of Breast Cancer Cells by Inhibiting CXCL11

“…Our finding was consistent with the result of the previous BC studies in terms of the ability of CXCL11 to promote tumor cell migration and invasion phenotypes. 22,24,25 Besides, we found that miR-1298-5p was the upstream miRNA of CXCL11 and that it could inhibit CXCL11 expression by binding to CXCL11 3ʹUTR, a result that was different from that of the previous study.…”

Citrus Flavones: An Update on Sources, Biological Functions, and Health Promoting Properties

“…In some tumors a great concentration of tumor necrosis factor α (TNF α) protein was found and transcriptomic analysis has demonstrated that apigenin is able to downregulate half of the genes that normally are upregulated by TNFα, all related to tumor promotion, invasion, and metastatic growth [108]. Interleukin-6 (IL-6) is another protein whose expression is negatively regulated by apigenin and the reduced expression affects not only tumor proliferation, but also migration and invasiveness [109].…”

A Novel Thienopyrimidine Analog, TPH104, Mediates Immunogenic Cell Death in Triple-Negative Breast Cancer Cells

“…Tumor-infiltrating lymphocytes (TILs) and tertiary lymphoid structures (TLSs) have favorable prognostic value in TNBC [ 20 ]. The immune response in tumors is mainly dependent on adaptive immunity mediated by T cells [ 21 ].…”